GlassScriptPhysician profile
Sanford M Archer
NPI 1396783411
$6,439.77
in general payments reported to CMS, 2019-2025
11 companies · $552 in 2025
The $552 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,019 · 2020: $270 · 2021: $757 · 2022: $349 · 2023: $259 · 2024: $235 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $3,760.89 | 2019-2021 | |
| Stryker Corporation | $1,443.76 | 2019-2023 | Audion Et Dilation System |
| Genzyme Corporation | $370.07 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $224.82 | 2019-2024 | Dupixent |
| Biotissue Holdings INC. | $150.81 | 2025 | |
| Glaxosmithkline, LLC. | $117.62 | 2025 | |
| Acclarent, INC | $94.45 | 2023 | Acclarent Aera |
| Integra Lifesciences Corporation | $92.05 | 2024 | Integra Duo, Microfrance, Codman Isocool Aht |
| Intersect Ent, INC. | $75.82 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $57.28 | 2021 | |
| Olympus America INC. | $52.20 | 2025 | Medical Control Unit For Endosurgery Uces-4 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanford Archer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.